In vivo assessment of amyloid‐β deposition in nondemented very elderly subjects

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Annals of Neurology

• Publication date

  2013-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/ana.23797PMID 23596051PMCID PMC3725727
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropathologic features associated with Alzheimer disease diagnosis

  2011cited by this paper
• Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old.

  2011cited by this paper
• Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.

  2010cited by this paper
• S5‐02‐05: Loss of structural, functional and effective connectivity of the visual system in healthy aging, mild cognitive impairment and Alzheimer's disease

  2010cited by this paper
• APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging

  2010cited by this paper
• Alzheimer disease identification using amyloid imaging and reserve variables

  2010cited by this paper
• Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET

  2010cited by this paper
• Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

  2010influential reference
• P3‐213: Amyloid‐related biomarkers for BACE1 inhibition in cell models of Alzheimer's disease

  2010cited by this paper
• Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging.

  2010cited by this paper
• The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core

  2010cited by this paper
• Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET images

  2010cited by this paper
• Pittsburgh Compound B (11C-PIB) and Fluorodeoxyglucose (18 F-FDG) PET in Patients With Alzheimer Disease, Mild Cognitive Impairment, and Healthy Controls

  2010cited by this paper
• Disruption of Functional Connectivity in Clinically Normal Older Adults Harboring Amyloid Burden

  2009cited by this paper
• Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial.

  2009cited by this paper
• Amyloid imaging in mild cognitive impairment subtypes

  2009cited by this paper
• Relationship of Cerebrospinal Fluid Markers to 11C-PiB and 18F-FDDNP Binding

  2009cited by this paper
• Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

  2009cited by this paper
• Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease.

  2009cited by this paper
• Comparison of 18F-FDG and PiB PET in Cognitive Impairment

  2009cited by this paper
• Conversion of amyloid positive and negative MCI to AD over 3 years

  2009cited by this paper
• Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease

  2009cited by this paper
• Age, neuropathology, and dementia.

  2009influential reference
• High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters.

  2009cited by this paper
• Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics.

  2009cited by this paper
• Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

  2009cited by this paper
• PET Amyloid Ligand [11C]PIB Uptake and Cerebrospinal Fluid β-Amyloid in Mild Cognitive Impairment

  2008cited by this paper
• Role of the neuropathology of Alzheimer disease in dementia in the oldest-old.

  2008cited by this paper
• Ginkgo biloba for prevention of dementia: a randomized controlled trial.

  2008influential reference
• PET imaging of amyloid deposition in patients with mild cognitive impairment.

  2008cited by this paper
• Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease

  2008cited by this paper
• Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease

  2008cited by this paper
• Frequent amyloid deposition without significant cognitive impairment among the elderly.

  2008cited by this paper
• Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study.

  2008cited by this paper
• Imaging beta-amyloid burden in aging and dementia.

  2007cited by this paper
• β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

  2007cited by this paper
• Imaging and CSF Studies in the Preclinical Diagnosis of Alzheimer's Disease

  2007cited by this paper
• Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

  2007cited by this paper
• 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease.

  2007cited by this paper
• Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease

  2006cited by this paper
• Potential antecedent marker of Alzheimer disease

  2006cited by this paper
• The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia.

  2006cited by this paper
• Alzheimer's and dementia in the oldest-old: a century of challenges.

  2006cited by this paper
• Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease

  2006cited by this paper
• [11C]PIB in a nondemented population

  2006cited by this paper
• Neuropathology of older persons without cognitive impairment from two community-based studies

  2006cited by this paper
• Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B

  2005cited by this paper
• Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions

  2005influential reference
• Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

  2004cited by this paper
• Incidence and Prevalence of Dementia in the Cardiovascular Health Study

  2004cited by this paper
• Risk Factors for Dementia in the Cardiovascular Health Cognition Study

  2003influential reference
• Phases of Aβ-deposition in the human brain and its relevance for the development of AD

  2002cited by this paper
• The APOE- (cid:101) 4 Allele and the Risk of Alzheimer Disease Among African Americans, Whites, and Hispanics

  2001cited by this paper
• Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study.

  1998cited by this paper
• Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease

  1998cited by this paper
• The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado.

  1995cited by this paper
• The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation.

  1993cited by this paper
• Very mild Alzheimer's disease

  1991cited by this paper

• Relationship of Alzheimer’s Disease and Related Dementias Plasma Biomarkers With Mobility in Cognitively Unimpaired Older Adults

  2025cites this paper
• Cerebellar atrophy in biologically confirmed Alzheimer's disease: Associations with amyloidopathy measured by cerebrospinal fluid biomarkers

  2025cites this paper
• Relationship between extracranial carotid artery calcification and amyloid-β deposition in the brain among the very old: A retrospective study

  2025cites this paper
• Association Between β-Amyloid Accumulation and Incident Dementia in Individuals 80 Years or Older Without Dementia.

  2024cites this paper
• Cerebral perfusion and amyloidosis in the oldest‐old

  2024cites this paper
• Imaging Methods Applicable in the Diagnostics of Alzheimer’s Disease, Considering the Involvement of Insulin Resistance

  2023cites this paper
• Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease

  2023cites this paper
• A History of Senile Plaques: From Alzheimer to Amyloid Imaging.

  2022cites this paper
• PET molecular imaging for pathophysiological visualization in Alzheimer’s disease

  2022cites this paper
• Effect of APOE ε4 genotype on amyloid‐β, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment

  2022cites this paper
• Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review

  2022cites this paper
• Uncovering the system vulnerability and criticality of human brain under evolving neuropathological events in Alzheimer’s disease

  2022cites this paper
• Uncovering the System Vulnerability and Criticality of Human Brain Under Dynamical Neuropathological Events in Alzheimer’s Disease

  2022cites this paper
• Comparing Pathological Risk Factors for Dementia between Cognitively Normal Japanese and Americans

  2021cites this paper
• Dementia or no dementia in the elderly. Why?

  2021cites this paper
• Neuroimaging in the Oldest-Old: A Review of the Literature

  2021cites this paper
• PET Agents in Dementia: An Overview.

  2021cites this paper
• What have we learned from cognition in the oldest-old

  2021cites this paper
• Peripheral Inflammatory Biomarkers Predict the Deposition and Progression of Amyloid-β in Cognitively Unimpaired Older Adults.

  2021cites this paper
• An Effect of Education on Memory-Encoding Activation in Subjective Cognitive Decline

  2021cites this paper
• Structural differences in amyloid-β fibrils from brains of nondemented elderly individuals and Alzheimer's disease patients

  2021cites this paper
• Polyphenols in neuroprotection and brain disorders

  2021cites this paper
• Brain SPECT as a Biomarker of Neurodegeneration in Dementia in the Era of Molecular Imaging: Still a Valid Option?

  2021cites this paper
• Overview of Alzheimer's and Parkinson's diseases and the role of protein aggregation in these neurodegenerative diseases

  2020cites this paper
• Cross-sectional associations of amyloid burden with semantic cognition in older adults without dementia: A systematic review and meta-analysis

  2020cites this paper
• Vascular contributions to cognitive impairment and dementia (VCID): A report from the 2018 National Heart, Lung, and Blood Institute and National Institute of Neurological Disorders and Stroke Workshop

  2020cites this paper
• Predicting resistance to amyloid-beta deposition and cognitive resilience in the oldest-old

  2020cites this paper
• Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories.

  2020influential citation
• The effect of amyloid deposition on longitudinal resting-state functional connectivity in cognitively normal older adults

  2020cites this paper
• Neuroimaging of Diseases Causing Dementia.

  2020cites this paper
• Longitudinal Maintenance of Cognitive Health in Centenarians in the 100-plus Study

  2020cites this paper
• Alcohol Consumption, Brain Amyloid-β Deposition, and Brain Structural Integrity Among Older Adults Free of Dementia

  2020cites this paper
• Emerging topics and practical aspects for an appropriate use of amyloid PET in the current Italian context.

  2019cites this paper
• Inflammation and Preclinical AD: Associations between Peripheral Inflammatory Biomarkers, Cognition, and Amyloid-B deposition in Non-demented Older Adults

  2019influential citation
• Relationship of amyloid-β1–42 in blood and brain amyloid: Ginkgo Evaluation of Memory Study

  2019influential citation
• Association Between Amyloid- β , Small-vessel Disease, and Neurodegeneration Biomarker Positivity, and Progression to Mild Cognitive Impairment in Cognitively Normal Individuals

  2019cites this paper
• The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies

  2019cites this paper
• Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease.

  2019cites this paper
• Association between Brain Amyloid, White Matter Hyperintensities and Hypometabolism, and Progression to Mild Cognitive Impairment in Cognitively Normal Individuals.

  2019cites this paper
• N-of-1 Clinical Trials in Nutritional Interventions Directed at Improving Cognitive Function

  2019cites this paper
• Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging

  2018cites this paper
• Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE &egr;4 genotype

  2018cites this paper
• Amyloid deposition and brain structure as long-term predictors of MCI, dementia, and mortality

  2018cites this paper
• The Relationship of Current Cognitive Activity to Brain Amyloid Burden and Glucose Metabolism.

  2018cites this paper
• Apolipoproteins and Alzheimer's pathophysiology

  2018cites this paper
• Preclinical PET imaging of Alzheimer's disease progression

  2017cites this paper
• Case 1-2017. A 70-Year-Old Woman with Gradually Progressive Loss of Language.

  2017cites this paper
• Future Directions in Imaging Neurodegeneration

  2017cites this paper
• Association of Brain Amyloid-&bgr; With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E &egr;4 Genotype

  2017cites this paper
• Small-molecule PET Tracers for Imaging Proteinopathies.

  2017cites this paper
• Polyphenols Beyond Barriers: A Glimpse into the Brain

  2017cites this paper
• The pleiotropic vasoprotective functions of high density lipoproteins (HDL)

  2017cites this paper
• Amyloid β Hypothesis in the Development of Therapeutic Agents for Alzheimer’s Disease

  2017cites this paper
• Detectable Neuropsychological Differences in Early Preclinical Alzheimer’s Disease: A Meta-Analysis

  2017influential citation
• Biomarkers for the Early Detection and Progression of Alzheimer’s Disease

  2016cites this paper
• Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia.

  2016cites this paper
• Genetic and degenerative disorders primarily causing dementia.

  2016cites this paper
• Peripheral Immune Signatures in Alzheimer Disease.

  2016cites this paper
• Cerebral Amyloid Deposition and Dual-Tasking in Cognitively Normal, Mobility Unimpaired Older Adults

  2016cites this paper
• Individual estimates of age at detectable amyloid onset for risk factor assessment

  2016cites this paper
• Psychological, behavioral and social effects of disclosing Alzheimer’s disease biomarkers to research participants: a systematic review

  2016cites this paper
• Molecular and cellular pathophysiology of preclinical Alzheimer's disease.

  2016cites this paper
• APOE4, oxidative stress and decreased repair capacity - a no-brainer. Faulty lipid metabolism and increased levels of oxidative damage may be risk factors in the pathogenesis of late-onset dementia

  2015influential citation
• Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer’s disease

  2015cites this paper
• Review of 'the potential role of arterial stiffness in the pathogenesis of Alzheimer's disease'.

  2015cites this paper
• Amyloid-beta and depression in healthy older adults: A systematic review

  2015cites this paper
• Reduced binding of Pittsburgh Compound-B in areas of white matter hyperintensities

  2015cites this paper
• Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum

  2015cites this paper
• APOε2 and education in cognitively normal older subjects with high levels of AD pathology at autopsy: findings from the Nun Study

  2015cites this paper
• Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results.

  2015cites this paper
• Subjective Cognitive Complaints, Personality and Brain Amyloid-beta in Cognitively Normal Older Adults.

  2015cites this paper
• Vascular Health Indices and Cognitive Domain Function: Singapore Longitudinal Ageing Studies

  2015cites this paper
• Amyloid PET imaging: applications beyond Alzheimer’s disease

  2015cites this paper
• Applied clinical neuroimaging in cerebral amyloid angiopathy and spontaneous intracerebral haemorrhage

  2015cites this paper
• Synergistic effects of ischemia and β-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment.

  2014cites this paper
• PET tracers for amyloid and other proteinopathies

  2014cites this paper
• Markers of cholesterol transport are associated with amyloid deposition in the brain.

  2014cites this paper
• Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old

  2014cites this paper
• Amyloid burden and neural function in people at risk for Alzheimer's Disease.

  2014cites this paper
• Arterial stiffness and β-amyloid progression in nondemented elderly adults.

  2014cites this paper
• Diagnostic Utility of Amyloid PET in Cerebral Amyloid Angiopathy-Related Symptomatic Intracerebral Hemorrhage

  2014cites this paper
• In vivo type 1 cannabinoid receptor availability in Alzheimer's disease.

  2014cites this paper
• Imaging Brain Effects of APOE4 in Cognitively Normal Individuals Across the Lifespan

  2014cites this paper
• The Relevance of Beta-Amyloid on Markers of Alzheimer’s Disease in Clinically Normal Individuals and Factors That Influence These Associations

  2014cites this paper
• The overlap between vascular disease and Alzheimer’s disease - lessons from pathology

  2014cites this paper
• The Relationship between Amyloid Deposition, Neurodegeneration, and Cognitive Decline in Dementia

  2014cites this paper
• Neuropathology of Dementia Disorders

  2014cites this paper
• Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults

  2013cites this paper
• Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers.

  2013cites this paper
• Cognitive trajectories associated with β-amyloid deposition in the oldest-old without dementia

  2013cites this paper
• Diet-Induced Ketosis and Calorie Restriction in Mouse Models of Alzheimer's Pathology

  2013cites this paper
• Classification of amyloid-positivity in controls: Comparison of visual read and quantitative approaches

  2013cites this paper
• The interest of amyloid PET imaging in the diagnosis of Alzheimer's disease.

  2013cites this paper
• The association of Aβ amyloid and composite cognitive measures in healthy older adults and MCI

  2013cites this paper
• Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings.

  2013cites this paper
• Depression, Suizidalität und Demenz im Alter

  2013cites this paper
• Hippocampal Glutamate NMDA Receptor Loss Tracks Progression in Alzheimer’s Disease: Quantitative Autoradiography in Postmortem Human Brain

  2013cites this paper
• The common dementias: a pictorial review

  2013influential citation
• Neuroimaging and genetic risk for Alzheimer’s disease and addiction-related degenerative brain disorders

  2013cites this paper
• Commons@Becker Digital Commons@Becker

  year unknowncites this paper